AdaptHealth (US.AHCO)

资本配置审计 · 期间: 20172026

$打开交互终端运行 `audit` 并探索所有维度。

核心指标

US.AHCO · 同比: 2026 H1 vs 2025 H1

指标数值同比
FCF Conversion-20.3%
ROE-10.9%
Cash Conversion-
D/E Ratio1.50
Gross Margin-9.6%
US.AHCO (AdaptHealth) | YoY: 2026 H1 vs 2025 H1


Metric            Value  YoY
----------------------------
FCF Conversion   -20.3%    ↓
ROE              -10.9%    ↓
Cash Conversion       -    →
D/E Ratio          1.50    ↓
Gross Margin      -9.6%    ↓
核心指标
US.AHCO (AdaptHealth) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY
----------------------------
FCF Conversion -20.3%
ROE -10.9%
Cash Conversion -
D/E Ratio 1.50
Gross Margin -9.6%

审计维度

免费公司